Search For "immunogenic"
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DC
Updated : 4 years, 10 months ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 10 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V C
Updated : 5 years, 3 months ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) has recommended additional immunogenicity data from Dr Reddy's Laboratories which applied to the national drugs regulator seeking emergency use approval for Sputnik
Read More
COVID-19 vaccine are safe and immunogenic, says Harsh Vardhan as he replie
Updated : 5 years, 3 months ago IST
New Delhi [India], February 11 (ANI): Replying to the concern of Chattisgarh Health Minister over COVID-19 vaccine, the Union Health Minister Dr Harsh Vardhan on Thursday said both the COVID-19 vaccines - Covaxin and Covishield are safe and immunogenic and should be used expeditiously to con
Read More
Pfizer showed no plans to generate safety data in Indian population for CO
Updated : 5 years, 3 months ago IST
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu
Read More
COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: L
Updated : 5 years, 4 months ago IST
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Read More
COVID-19 vaccine may cost between Rs 200 to 295 in India: Health Ministry
Updated : 5 years, 4 months ago IST
New Delhi [India], January 12 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use Authorisation (EAU) after going through established saf
Read More
Emergency use of vaccine is based on safety, immunogenicity data, says ICM
Updated : 5 years, 4 months ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
Covishield safe, immunogenic; incident with Chennai volunteer no way induc
Updated : 5 years, 5 months ago IST
New Delhi [India], December 1 (ANI): Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as "requisite regulatory and ethical processes and guideline"
Read More
Submit previous trial data for Covaxin before rolling out phase III: Drug
Updated : 5 years, 7 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Read More
DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine
Updated : 5 years, 8 months ago IST
New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
Read More
Oxford's coronavirus vaccine 'safe, immunogenic': Study
Updated : 5 years, 10 months ago IST
London [UK], July 20 (ANI): A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet.
Read More